BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8754795)

  • 1. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact.
    Jimi E; Nakamura I; Amano H; Taguchi Y; Tsurukai T; Tamura M; Takahashi N; Suda T
    Endocrinology; 1996 Aug; 137(8):2187-90. PubMed ID: 8754795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact.
    Jimi E; Nakamura I; Amano H; Taguchi Y; Tsurukai T; Tamura M; Takahashi N; Suda T
    Endocrinology; 1996 May; 137(5):2187-90. PubMed ID: 8612568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
    Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T
    Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells.
    Udagawa N; Takahashi N; Akatsu T; Sasaki T; Yamaguchi A; Kodama H; Martin TJ; Suda T
    Endocrinology; 1989 Oct; 125(4):1805-13. PubMed ID: 2676473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders.
    Murakami H; Takahashi N; Sasaki T; Udagawa N; Tanaka S; Nakamura I; Zhang D; Barbier A; Suda T
    Bone; 1995 Aug; 17(2):137-44. PubMed ID: 8554921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells.
    Yamashita T; Asano K; Takahashi N; Akatsu T; Udagawa N; Sasaki T; Martin TJ; Suda T
    J Cell Physiol; 1990 Dec; 145(3):587-95. PubMed ID: 1703173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation.
    Nishiyama K; Sugimoto T; Kaji H; Kanatani M; Kobayashi T; Chihara K
    Endocrinology; 1996 Jan; 137(1):35-41. PubMed ID: 8536635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor.
    Oba Y; Chung HY; Choi SJ; Roodman GD
    J Bone Miner Res; 2003 Jul; 18(7):1332-41. PubMed ID: 12854845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A third-generation bisphosphonate, YM175, inhibits osteoclast formation in murine cocultures by inhibiting proliferation of precursor cells via supporting cell-dependent mechanisms.
    Nishikawa M; Yamamoto M; Murakami T; Akatsu T; Kugai N; Nagata N
    J Bone Miner Res; 1998 Jun; 13(6):986-95. PubMed ID: 9626630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of a mouse osteoclast-like multinucleated cell population.
    Akatsu T; Tamura T; Takahashi N; Udagawa N; Tanaka S; Sasaki T; Yamaguchi A; Nagata N; Suda T
    J Bone Miner Res; 1992 Nov; 7(11):1297-306. PubMed ID: 1281605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells.
    Kaji H; Sugimoto T; Kanatani M; Chihara K
    J Bone Miner Res; 1996 Jul; 11(7):912-20. PubMed ID: 8797111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of low molecular weight chitosan on bone resorption in vitro and in vivo.
    Li H; Miyahara T; Tezuka Y; Watanabe M; Nemoto N; Seto H; Kadota S
    Phytomedicine; 1999 Nov; 6(5):305-10. PubMed ID: 11962535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function.
    Rao H; Lu G; Kajiya H; Garcia-Palacios V; Kurihara N; Anderson J; Patrene K; Sheppard D; Blair HC; Windle JJ; Choi SJ; Roodman GD
    J Bone Miner Res; 2006 Oct; 21(10):1657-65. PubMed ID: 16995821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts.
    Nakamura I; Takahashi N; Sasaki T; Jimi E; Kurokawa T; Suda T
    J Bone Miner Res; 1996 Dec; 11(12):1873-9. PubMed ID: 8970888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts.
    Chihara K; Sugimoto T
    Horm Res; 1997; 48 Suppl 5():45-9. PubMed ID: 9434044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
    Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts.
    Suzuki H; Nakamura I; Takahashi N; Ikuhara T; Matsuzaki K; Isogai Y; Hori M; Suda T
    Endocrinology; 1996 Nov; 137(11):4685-90. PubMed ID: 8895334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New resorption assay with mouse osteoclast-like multinucleated cells formed in vitro.
    Tamura T; Takahashi N; Akatsu T; Sasaki T; Udagawa N; Tanaka S; Suda T
    J Bone Miner Res; 1993 Aug; 8(8):953-60. PubMed ID: 7692706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of mouse osteoclastogenic cell lines immortalized with SV40 large T antigen.
    Chen W; Li YP
    J Bone Miner Res; 1998 Jul; 13(7):1112-23. PubMed ID: 9661075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.